The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer

por Cabello, Paula, Pineda, Begoña, Tormo, Eduardo, Lluch, Ana, Eroles, Pilar
Publicado 2016

Associations between Aromatase CYP19 rs10046 Polymorphism and Breast Cancer Risk: From a Case-Control to a Meta-Analysis of 20,098 Subjects

por Pineda, Begoña, García-Pérez, Miguel Ángel, Cano, Antonio, Lluch, Ana, Eroles, Pilar
Publicado 2013

Identification of Candidate Polymorphisms on Stress Oxidative and DNA Damage Repair Genes Related with Clinical Outcome in Breast Cancer Patients

por Rodrigues, Patricia, Furriol, Jessica, Bermejo, Begoña, Chaves, Felipe Javier, Lluch, Ana, Eroles, Pilar
Publicado 2012

Clinical Relevance of +936 C>T VEGFA and c.233C>T bFGF Polymorphisms in Chronic Lymphocytic Leukemia

por Ballester, Sandra, Pineda, Begoña, Rodrigues, Patricia, Tormo, Eduardo, Terol, María José, Eroles, Pilar
Publicado 2020

Antagonists of the Mu-Opioid Receptor in the Cancer Patient: Fact or Fiction?

por Belltall, Amparo, Mazzinari, Guido, Diaz-Cambronero, Oscar, Eroles, Pilar, Argente Navarro, María Pilar
Publicado 2022

Synthesis of 2-aminopropyl benzopyran derivatives as potential agents against triple-negative breast cancer

por García, Ainhoa, Torres-Ruiz, Sandra, Vila, Laura, Villarroel-Vicente, Carlos, Bernabeu, Álvaro, Eroles, Pilar, Cabedo, Nuria, Cortes, Diego
Publicado 2023

MicroRNAs as a clue to overcome breast cancer treatment resistance

por Garrido-Cano, Iris, Pattanayak, Birlipta, Adam-Artigues, Anna, Lameirinhas, Ana, Torres-Ruiz, Sandra, Tormo, Eduardo, Cervera, Raimundo, Eroles, Pilar
Publicado 2021

miRNA Expression Analysis: Cell Lines HCC1500 and HCC1937 as Models for Breast Cancer in Young Women and the miR-23a as a Poor Prognostic Biomarker

por Oltra, Sara S, Peña-Chilet, Maria, Martinez, Maria T, Tormo, Eduardo, Cejalvo, Juan Miguel, Climent, Joan, Eroles, Pilar, Lluch, Ana, Ribas, Gloria
Publicado 2020

Solid Tumor Opioid Receptor Expression and Oncologic Outcomes: Analysis of the Cancer Genome Atlas and Genotype Tissue Expression Project

por Belltall, Amparo, Zúñiga-Trejos, Sheila, Garrido-Cano, Iris, Eroles, Pilar, Argente-Navarro, Maria Pilar, Buggy, Donal J., Díaz-Cambronero, Oscar, Mazzinari, Guido
Publicado 2022

The role of miR-26a and miR-30b in HER2+ breast cancer trastuzumab resistance and regulation of the CCNE2 gene

por Tormo, Eduardo, Adam-Artigues, Anna, Ballester, Sandra, Pineda, Begoña, Zazo, Sandra, González-Alonso, Paula, Albanell, Joan, Rovira, Ana, Rojo, Federico, Lluch, Ana, Eroles, Pilar
Publicado 2017

The Novel Oral mTORC1/2 Inhibitor TAK-228 Reverses Trastuzumab Resistance in HER2-Positive Breast Cancer Models

por Sanz-Álvarez, Marta, Martín-Aparicio, Ester, Luque, Melani, Zazo, Sandra, Martínez-Useros, Javier, Eroles, Pilar, Rovira, Ana, Albanell, Joan, Madoz-Gúrpide, Juan, Rojo, Federico
Publicado 2021

Opioid Receptor Expression in Colorectal Cancer: A Nested Matched Case-Control Study

por Belltall, Amparo, Mazzinari, Guido, Garrido-Cano, Iris, Giner, Francisco, Marí, Anabel Marqués, Eroles, Pilar, Argente-Navarro, María Pilar, Cata, Juan Pablo, Diaz-Cambronero, Oscar
Publicado 2022

A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients

por Pineda, Begoña, Diaz-Lagares, Angel, Pérez-Fidalgo, José Alejandro, Burgués, Octavio, González-Barrallo, Inés, Crujeiras, Ana B., Sandoval, Juan, Esteller, Manel, Lluch, Ana, Eroles, Pilar
Publicado 2019

Role of SALL4 in HER2+ Breast Cancer Progression: Regulating PI3K/AKT Pathway

por Pattanayak, Birlipta, Lameirinhas, Ana, Torres-Ruiz, Sandra, Burgués, Octavio, Rovira, Ana, Martínez, María Teresa, Tapia, Marta, Zazo, Sandra, Albanell, Joan, Rojo, Federico, Bermejo, Begoña, Eroles, Pilar
Publicado 2022

Mu Opioid Receptor 1 (MOR-1) Expression in Colorectal Cancer and Oncological Long-Term Outcomes: A Five-Year Retrospective Longitudinal Cohort Study

por Díaz-Cambronero, Oscar, Mazzinari, Guido, Giner, Francisco, Belltall, Amparo, Ruiz-Boluda, Lola, Marqués-Marí, Anabel, Sánchez-Guillén, Luis, Eroles, Pilar, Cata, Juan Pablo, Argente-Navarro, María Pilar
Publicado 2020

Oral Selective Estrogen Receptor Degraders (SERDs) as a Novel Breast Cancer Therapy: Present and Future from a Clinical Perspective

por Hernando, Cristina, Ortega-Morillo, Belén, Tapia, Marta, Moragón, Santiago, Martínez, María Teresa, Eroles, Pilar, Garrido-Cano, Iris, Adam-Artigues, Anna, Lluch, Ana, Bermejo, Begoña, Cejalvo, Juan Miguel
Publicado 2021

CIP2A as a Key Regulator for AKT Phosphorylation Has Partial Impact Determining Clinical Outcome in Breast Cancer

por Luque, Melani, Cristóbal, Ion, Sanz-Álvarez, Marta, Santos, Andrea, Zazo, Sandra, Eroles, Pilar, Arpí, Oriol, Rovira, Ana, Albanell, Joan, Madoz-Gúrpide, Juan, García-Foncillas, Jesús, Rojo, Federico
Publicado 2022

Delivery of miR-200c-3p Using Tumor-Targeted Mesoporous Silica Nanoparticles for Breast Cancer Therapy

por Garrido-Cano, Iris, Adam-Artigues, Anna, Lameirinhas, Ana, Blandez, Juan F., Candela-Noguera, Vicente, Lluch, Ana, Bermejo, Begoña, Sancenón, Felix, Cejalvo, Juan Miguel, Martínez-Máñez, Ramón, Eroles, Pilar
Publicado 2023

PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects

por Rincón, Raúl, Cristóbal, Ion, Zazo, Sandra, Arpí, Oriol, Menéndez, Silvia, Manso, Rebeca, Lluch, Ana, Eroles, Pilar, Rovira, Ana, Albanell, Joan, García-Foncillas, Jesús, Madoz-Gúrpide, Juan, Rojo, Federico
Publicado 2015

Expression of Phosphorylated BRD4 Is Markedly Associated with the Activation Status of the PP2A Pathway and Shows a Strong Prognostic Value in Triple Negative Breast Cancer Patient...

por Sanz-Álvarez, Marta, Cristóbal, Ion, Luque, Melani, Santos, Andrea, Zazo, Sandra, Madoz-Gúrpide, Juan, Caramés, Cristina, Chiang, Cheng-Ming, García-Foncillas, Jesús, Eroles, Pilar, Albanell, Joan, Rojo, Federico
Publicado 2021